NORTH SHORE-LIJ CANCER INSTITUTE opened a $47 million radiation therapy facility.
MARGARET DIMOND was named president of the Karmanos Cancer Hospital, effective immediately.
JOHN CZAJKOWSKI, NCI deputy director for management, has accepted a position as executive dean of administration at Harvard Medical School. His start date will be June 2.
Victor Dzau, chancellor of health affairs at Duke University and president and CEO of the Duke University Health System, was named president of the Institute of Medicine.
FDA needs to improve its access to data if it is to manage drug shortages more effectively, the Government Accountability Office concluded.
Enrollment in NCI-sponsored National Clinical Trials Network clinical trials will drop to about 17,500 this fiscal year, the network groups have been told by NCI officials.
NCI has launched a pilot study to assess whether assigning cancer patients treatment based on the genetic characteristics of their disease can improve outcomes for patients with advanced metastatic solid tumors.
ISSAM MAKHOUL was named the inaugural recipient of the Laura F. Hutchins, M.D. Distinguished Chair for Hematology and Oncology at the University of Arkansas for Medical Sciences.
AVEO ONCOLOGY and Astellas Pharma Inc. will end an agreement to develop the investigational cancer drug tivozanib by Aug. 11.
JIM ALLISON has been awarded the 2014 Szent-Györgyi Prize for Progress in Cancer Research from the National Foundation for Cancer Research.
